Bayer eye drug succeeds in long-term study
February 21, 2012Research and Development, Sales and Marketing Bayer, Lucentis, aflibercept, wet AMD
Bayer’s eye drug aflibercept has succeeded in a long-term study in patients with a common eye condition. The Phase III …
MHRA suspends Teva licence for levothyroxine generic
February 21, 2012Manufacturing and Production MHRA, Numark, Teva, levothyroxine
The UK medicine regulatory authority has suspended the licence for a levothyroxine product sold by Teva on the grounds that …
Contract research news in brief
February 21, 2012Research and Development Almac, GVK Biosciences and PreClinOmics/AIT, PPD, Quintiles
Our round-up of news from the contract research sector includes PPD’s sales to a private equity consortium, new clinical supply …
Asymchem plans additional investment in Dunhua facility
February 21, 2012Manufacturing and Production Asymchem, China, Dunhua, manufacturing
China’s Asymchem Laboratories says it plans to invest another $12 million in its recently-opened manufacturing facility in Dunhua, Jilin province, …
Setback for Gilead hep C candidate
February 20, 2012Research and Development, Sales and Marketing ELECTRON, GS-7977, Gilead, Pharmasset
Gilead’s investigational hepatitis C drug has been dealt a blow after patients suffer relapses in a mid-stage trial. In the …
Shortages likely as Sandoz’s Canadian plant woes continue
February 20, 2012Manufacturing and Production FDA, Novartis, Sandoz
Ongoing compliance problems at a plant in Canada operated by Novartis’ generics subsidiary Sandoz look set to cause supply disruptions …
Pfizer closes in on $545m China generics deal
February 20, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing China, Hisun, Pfizer, Zhejiang, generics
Pfizer has moved a step closer to a deal with Shanghai-based Zhejiang Hisun Pharmaceutical to develop generic drugs in China. …
Health Information appoints Nigel Brooksby as its deputy chairman
February 20, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Brooksby, Health Information
Health Information, a provider of medicine adherence services in the UK, has appointed former ABPI president Nigel Brooksby as its …
European approval for Roche’s Zelboraf
February 20, 2012Sales and Marketing Cancer, Roche, Yervoy, Zelboraf, melanoma
Roche’s skin cancer pill Zelboraf has been given European approval to treat advanced melanoma. Zelboraf (vemurafenib) is now available in …
GSK pulls Tyverb extension in Europe
February 17, 2012Sales and Marketing GSK, Herceptin, Tyverb, Xeloda
GlaxoSmithKline has withdrawn its European application to extend the licence of its breast cancer pill Tyverb. The firm was seeking …
UCB releases ‘Epilepsy In Our Time’ video diaries
February 17, 2012Medical Communications UCB, epilepsy
UCB has released Epilepsy In Our Time, a video diary that explores life with epilepsy from the perspective of those …
Life tops up its team with two new appointments
February 17, 2012Medical Communications Life healthcare communications
Life Healthcare Communications has made two new appointments, growing its client service and production departments. Matt Leeming joins Life as …
NICE no for first line Tarceva
February 17, 2012Sales and Marketing CDF, Cancer, NICE, Roche, Tarceva
NICE no for first line Tarceva Watchdog wants more information on Roche’s drug NICE is not recommending Roche’s lung cancer …
Merck unveils Brazilian joint venture
February 17, 2012Sales and Marketing Brazil, Merck & Co, Supera Farma, emerging markets
Merck Inc has bolstered its presence in emerging markets by entering a joint venture with Brazilian firm Supera Farma Laboratorios. Due …
Cimzia results excite UCB in psoriatic arthritis
February 16, 2012Research and Development, Sales and Marketing Cimzia, UCB, psoriatic arthritis
UCB will submit Cimzia for psoriatic arthritis by the end of 2012, after positive Phase III trial results for the …
Words – the most powerful drug
February 16, 2012Medical Communications
Why good internal communication within organisations is essential in these fraught timesBy William Hind, Founder – AlpharmaximThe precise quote by …
Panu Miettinen appointed chief financial officer of Biotie
February 16, 2012Business Services, Research and Development, Sales and Marketing Biotie, Panu Miettinen
Panu Miettinen, 43, has been appointed chief financial officer of Biotie Therapies. He will become a member of the Group’s …
EMA appoints new head of information and communications technology
February 16, 2012Business Services, Medical Communications, Sales and Marketing EMA, Luc Verhelst
Luc Verhelst has been appointed as the new head of the European Medicines Agency’s information and communications technology unit. Verhelst …
MRN launches online training portal
February 16, 2012Research and Development
16 February 2012 – Medical Research Network (MRN), the unique Clinical Trial Support Organisation (CTSO) offering home trial support, site …
NICE frowns on Botox for headache prevention
February 16, 2012Sales and Marketing Allergan, Botox, EMA, NHS, NICE
NICE is not recommending Allergan’s Botox for headache prevention, and has asked the firm for more information on the drug. …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
